Cho, Byoung Chul

Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors

Kim, H. S., Shin, S. J., Kim, S. C., An, S., Rha, S. Y., Ahn, J. B., Cho, B. C., Choi, H. J., Sohn, J. H., Kim, H. S., et al. (2013) · Supportive Care in Cancer

Pain Management and Opioid UseCancer survivorship and care

Cited by 47

KontRASt-01 update: Safety and efficacy of JDQ443 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC).

Cassier, P. A., Dooms, C. A., Gazzah, A., Felip, E., Steeghs, N., Rohrberg, K. S., De Braud, F. G., Solomon, B. J., Schuler, M. H., Tan, D. S.-W., et al. (2023) · Journal of Clinical Oncology

Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling

Cited by 35

MA06.03 KontRASt-01: Preliminary Safety and Efficacy of JDQ443 + TNO155 in Patients with Advanced, KRAS G12C-Mutated Solid Tumors

Negrao, M. V., Cassier, P. A., Solomon, B., Schuler, M., Rohrberg, K., Cresta, S., Dooms, C., Tan, D. S. W., Loong, H. H.-F., Amatu, A., et al. (2023) · Journal of Thoracic Oncology

Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling

Cited by 28

Abstract PR07: AZD9291 activity in patients with leptomeningeal disease from non-small cell lung cancer: a Phase I study

Lee, D. H., Kim, D.-W., Ahn, M.-J., Cho, B. C., Lee, J. S., Ye, X., Yang, P., Jiang, H., & Yang, J. C.-H. (2015) · Molecular Cancer Therapeutics

Lung Cancer Treatments and MutationsBrain Metastases and Treatment

Cited by 7

Abstract CT036: Bioavailability of MK-3475A (pembrolizumab with berahyaluronidase alfa; “subcutaneous pembrolizumab”) in participants with advanced or metastatic solid tumors

Torras, O. R., Cohen, G., Cho, B. C., Rojas, C., Walton, C., Medina, L., Khanyile, R., Papai, Z., Lala, M., Song, G., et al. (2025) · Cancer Research

Cancer Immunotherapy and BiomarkersBiosimilars and Bioanalytical Methods

Cited by 3